{"id":610,"date":"2026-09-29T09:56:14","date_gmt":"2026-09-29T04:26:14","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/"},"modified":"2026-09-29T19:13:43","modified_gmt":"2026-09-29T13:43:43","slug":"glenmark-share-price-today-2026-09-29","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/","title":{"rendered":"Glenmark Pharma Shares Surge 5%: Why Glenmark Stock is Rising Today"},"content":{"rendered":"<style>\n      .wt-grid > * { min-width:0; width:100%; }\n      .wt-grid table { width:100%; }\n      .wt-intro { margin:10px 0 16px; line-height:1.55; }\n      .wt-intro strong { white-space:nowrap; }\n      @media (max-width: 760px) {\n        .wt-grid { grid-template-columns:1fr !important; }\n      }\n    <\/style>\n<div style=\"display:flex;flex-wrap:wrap;justify-content:space-between;gap:8px 18px;align-items:center;padding:10px 14px;margin:0 0 14px;background:#f7f9fc;border:1px solid #e1e7ef;border-radius:8px;font-size:13px;line-height:1.45;\">\n      <span><strong>Market Data:<\/strong> 29 Sep 2026 \u2022 03:10 PM IST<\/span><br \/>\n      <span><strong>Status:<\/strong> Automated market-move research draft<\/span>\n    <\/div>\n<div class=\"company-brand\">\n<div class=\"company-details\">\n        <span class=\"company-name\">GLENMARK PHARMACEUTICALS<\/span><br \/>\n        <span class=\"company-symbol\">GLENMARK \u2022 NSE \u2022 F&amp;O Stock<\/span>\n      <\/div>\n<div class=\"company-move up\" style=\"background:#e8f7ef;border:1px solid #bfe3cf;color:#08754f;-webkit-text-fill-color:#08754f;\">+4.98%<\/div>\n<\/p><\/div>\n<p class=\"wt-intro\">GLENMARK PHARMACEUTICALS traded at <strong>\u20b92,441.50<\/strong>, +4.98% versus the previous close of \u20b92,325.70. <strong>Latest market data: 29 Sep 2026 \u2022 03:10 PM IST.<\/strong><\/p>\n<div style=\"background:#f7fbff;border:1px solid #cfe1f2;border-left:5px solid #2e7db2;border-radius:10px;padding:15px 17px;margin:14px 0 18px;\">\n<div style=\"font-size:15px;font-weight:900;color:#1f4d70;margin-bottom:7px;\">Key Takeaways<\/div>\n<ul style=\"margin:0;padding-left:18px;line-height:1.55;\">\n<li>The stock is +4.98% at \u20b92,441.50.<\/li>\n<li><strong>Likely reason:<\/strong> Strong volume-backed buying and sector outperformance<\/li>\n<li>Approximate traded value is <strong>\u20b9307.19 crore<\/strong>.<\/li>\n<li>It is -3.79% from its 52-week high and +36.20% from its 52-week low.<\/li>\n<li>The stock is being compared with <strong>Nifty Pharma<\/strong> alongside the Nifty 50.<\/li>\n<\/ul><\/div>\n<div class=\"market-snapshot\">\n<h2>GLENMARK PHARMACEUTICALS Share Price Today \u2013 Market Snapshot<\/h2>\n<div style=\"display:grid;grid-template-columns:repeat(5,minmax(0,1fr));gap:10px;margin-top:12px;width:100%;box-sizing:border-box;\">\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Symbol<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">GLENMARK<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Date &amp; Time<\/div>\n<div style=\"font-size:14px;font-weight:800;color:#17324d;\">29 Sep 2026 \u2022 03:10 PM IST<\/div>\n<\/div>\n<div style=\"background:#e8f7ef;border:1px solid #bfe3cf;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#08754f;font-weight:800;\">Change<\/div>\n<div style=\"font-size:17px;font-weight:900;color:#08754f;-webkit-text-fill-color:#08754f;\">+4.98%<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Previous Close<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,325.70<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Open<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,342.20<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Day High<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,441.50<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Day Low<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,292.10<\/div>\n<\/div>\n<div style=\"background:#eef5ff;border:1px solid #cdddf4;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#536d91;font-weight:800;\">Price \/ Close<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,441.50<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Volume<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">1,258,203<\/div>\n<\/div>\n<div style=\"background:#fff7e9;border:1px solid #edd9ad;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#866a32;font-weight:800;\">52-Week Range<\/div>\n<div style=\"font-size:14px;font-weight:900;color:#694d1e;\">\u20b91,792.60 \u2013 \u20b92,537.60<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<h2>Why Is GLENMARK PHARMACEUTICALS Share Price Rising Today?<\/h2>\n<div class=\"wt-prose\">\n<p>Glenmark Pharmaceuticals shares surged 4.98% to close at \u20b92,441.50 today, trading aggressively near the upper end of its intraday range between \u20b92,292.10 and \u20b92,441.50. Market participation was exceptionally strong, with trading volume clocking over 2.5 times its 20-day average and delivery quantity scaling up to 65.75%, signalling heavy institutional or delivery-based accumulation.<\/p>\n<p>The stock notably outperformed the broader market and its sectoral peers. While the benchmark Nifty dipped 0.28%, the Nifty Pharma sector index posted a modest 0.64% gain, making Glenmark&#x27;s sharp upward trajectory one of the standout movers in the pharmaceutical space.<\/p>\n<p>While no single headline-grabbing catalyst dropped today, the stock&#x27;s robust momentum coincides with a series of positive regulatory and operational updates over the past weeks, including the U.S. FDA&#x27;s VAI classification and Establishment Inspection Report (EIR) for its Goa facility, alongside the global expansion of its respiratory footprint with the Ryaltris launch in Brazil.<\/p>\n<\/div>\n<div style=\"border:1px solid #c9d9e7;border-left:5px solid #1f7b92;border-radius:10px;background:#f5fbfd;padding:16px 18px;margin:16px 0 22px;\">\n<div style=\"display:flex;gap:10px;align-items:center;flex-wrap:wrap;margin-bottom:7px;\">\n<div style=\"font-size:15px;font-weight:900;color:#174c5d;\">Likely Reason for Today&#8217;s Move<\/div>\n<p>        <span style=\"display:inline-block;background:#fff1cf;color:#8a6116;padding:3px 8px;border-radius:999px;font-size:11px;font-weight:900;text-transform:uppercase;\">medium confidence<\/span>\n      <\/div>\n<div style=\"font-size:16px;font-weight:850;color:#20384a;margin-bottom:7px;\">Strong volume-backed buying and sector outperformance<\/div>\n<div style=\"line-height:1.58;\">Glenmark rallied sharply by nearly 5% accompanied by massive volume expansion (2.5x of 20-day average) and high delivery percentage, outpacing the broader pharmaceutical index. The move appears supported by recent positive regulatory developments like the U.S. FDA clearance for the Goa plant and institutional accumulation.<\/div>\n<ul style='margin:10px 0 0;padding-left:18px;'>\n<li>Daily return of +4.98% with heavy volumes at 2.57x the 20-day average<\/li>\n<li>High delivery percentage of 65.75% indicating strong institutional interest<\/li>\n<li>Outperformance against Nifty (-0.28%) and Nifty Pharma (+0.64%)<\/li>\n<\/ul><\/div>\n<div style=\"background:linear-gradient(120deg,#123b63,#1d5f82 58%,#0d7a70);border-radius:12px;padding:22px 26px;margin:22px 0 26px;text-align:center;box-shadow:0 8px 20px rgba(25,66,93,.14);width:100%;box-sizing:border-box;\">\n<div style=\"font-size:19px;font-weight:900;color:#fff;-webkit-text-fill-color:#fff;margin-bottom:7px;\">Understand the Move Beyond the Headline<\/div>\n<div style=\"font-size:14px;line-height:1.5;color:#eef8fb;-webkit-text-fill-color:#eef8fb;margin-bottom:13px;\">Explore WittyTrades research across price action, volume, derivatives, company developments and market context.<\/div>\n<p>      <a href=\"https:\/\/www.wittytrades.com\/Segments.html\" style=\"display:inline-block;background:#ffffff;color:#14566d;-webkit-text-fill-color:#14566d;text-decoration:none;font-weight:900;padding:10px 20px;border-radius:6px;\">Explore Research Plans<\/a>\n    <\/div>\n<h2>Performance Context<\/h2>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:repeat(5,minmax(0,1fr));gap:10px;margin:12px 0 22px;\">\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#6b7888;font-weight:800;\">TODAY<\/div>\n<div style=\"font-size:15px;font-weight:900;\">+4.98%<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#6b7888;font-weight:800;\">5 DAYS<\/div>\n<div style=\"font-size:15px;font-weight:900;\">-0.81%<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#6b7888;font-weight:800;\">20 DAYS<\/div>\n<div style=\"font-size:15px;font-weight:900;\">-1.17%<\/div>\n<\/div>\n<div style=\"background:#fff7e9;border:1px solid #edd9ad;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#7a673c;font-weight:800;\">VS 52W HIGH<\/div>\n<div style=\"font-size:15px;font-weight:900;\">-3.79%<\/div>\n<\/div>\n<div style=\"background:#eef8f3;border:1px solid #cbe5d8;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#46715d;font-weight:800;\">FROM 52W LOW<\/div>\n<div style=\"font-size:15px;font-weight:900;\">+36.20%<\/div>\n<\/div><\/div>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:1fr 1fr;gap:16px;margin:20px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #b8dfd4;border-radius:12px;background:#eaf8f4;padding:17px;box-sizing:border-box;min-width:0;\">\n<h3 style=\"margin:0 0 4px;color:#155f52;\">Cash-Market Activity<\/h3>\n<div style=\"font-size:12px;color:#5d776f;margin-bottom:10px;\">Latest NSE EOD report: 2026-09-29<\/div>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>Today&#8217;s Volume<\/th>\n<td>1,258,203<\/td>\n<\/tr>\n<tr>\n<th>5-Day Avg. Volume<\/th>\n<td>817,296<\/td>\n<\/tr>\n<tr>\n<th>20-Day Avg. Volume<\/th>\n<td>488,980<\/td>\n<\/tr>\n<tr>\n<th>Volume vs 20-Day Avg.<\/th>\n<td>2.57x<\/td>\n<\/tr>\n<tr>\n<th>Delivery Quantity<\/th>\n<td>839,781<\/td>\n<\/tr>\n<tr>\n<th>Delivery %<\/th>\n<td>65.75%<\/td>\n<\/tr>\n<tr>\n<th>Number of Trades<\/th>\n<td>56,808<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<div style=\"border:1px solid #cec8ef;border-radius:12px;background:#f2efff;padding:17px;box-sizing:border-box;min-width:0;\">\n<h3 style=\"margin:0 0 4px;color:#514694;\">Derivative-Market Activity<\/h3>\n<div style=\"font-size:12px;color:#6e668e;margin-bottom:10px;\">NSE F&amp;O EOD report: 2026-09-28 \u2022 Expiry: 2026-09-29<\/div>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>Near-Month Futures<\/th>\n<td>\u20b92,316.30<\/td>\n<\/tr>\n<tr>\n<th>Cash Reference<\/th>\n<td>\u20b92,325.75<\/td>\n<\/tr>\n<tr>\n<th>Premium \/ Discount<\/th>\n<td>\u20b9-9.45 (-0.41%)<\/td>\n<\/tr>\n<tr>\n<th>Change in Premium<\/th>\n<td>\u20b9-3.85<\/td>\n<\/tr>\n<tr>\n<th>Futures Volume<\/th>\n<td>8,501<\/td>\n<\/tr>\n<tr>\n<th>Volume vs Previous Session<\/th>\n<td>0.77x<\/td>\n<\/tr>\n<tr>\n<th>Open Interest<\/th>\n<td>1,012,875<\/td>\n<\/tr>\n<tr>\n<th>OI vs Previous Session<\/th>\n<td>0.27x<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/p><\/div>\n<h2>Recent Brokerage Views<\/h2>\n<div style=\"border:1px solid #cbd8ea;border-radius:12px;padding:14px;background:#f4f8fd;box-sizing:border-box;width:100%;\">\n<div style=\"width:100%;box-sizing:border-box;border:1px solid #cbd8ea;border-radius:10px;background:#fff;padding:14px 15px;margin-bottom:12px;\">\n<div class=\"wt-broker-row\" style=\"display:grid;grid-template-columns:1.25fr .85fr .85fr .85fr;gap:10px;width:100%;box-sizing:border-box;align-items:stretch;\">\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"font-size:11px;text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Brokerage<\/div>\n<div style=\"font-size:14px;font-weight:800;color:#21384f;\">Motilal Oswal<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"font-size:11px;text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">View<\/div>\n<div style=\"font-size:14px;font-weight:800;color:#21384f;\">Buy<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"font-size:11px;text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Target<\/div>\n<div style=\"font-size:14px;font-weight:800;color:#21384f;\">\u20b92,570<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"font-size:11px;text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Date<\/div>\n<div style=\"font-size:14px;font-weight:800;color:#21384f;\">31 Aug 2026<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"margin-top:10px;background:#f8fafc;border:1px solid #e4eaf1;border-radius:8px;padding:11px 12px;line-height:1.5;\"><strong>Key rationale \/ reported context:<\/strong> Recommended as a stock pick by analyst Chandan Taparia, backed by favorable technical setups and structural business momentum.<\/div>\n<\/p><\/div>\n<p style=\"margin:8px 2px 0;\"><em>Brokerage views are third-party opinions and are not WittyTrades recommendations.<\/em><\/p>\n<\/p><\/div>\n<div class=\"witty-insight\">\n<h3>WittyTrades Data Insight<\/h3>\n<p><strong>Price Position:<\/strong> The stock is near the upper end of the day&#8217;s trading range.<\/p>\n<p><strong>Move From Open:<\/strong> +4.24%.<\/p>\n<p><strong>Intraday Range:<\/strong> 6.42% of the previous close.<\/p>\n<p><strong>5-Day Performance:<\/strong> -0.81%; <strong>20-Day Performance:<\/strong> -1.17%.<\/p>\n<\/p><\/div>\n<div style=\"background:linear-gradient(120deg,#243467,#4a3f8d 58%,#136c74);border-radius:12px;padding:24px 28px;margin:28px 0;text-align:center;box-shadow:0 8px 20px rgba(35,31,89,.16);\">\n<div style=\"font-size:20px;font-weight:900;color:#fff;-webkit-text-fill-color:#fff;margin-bottom:8px;\">Beyond Charts \u2014 Research Backed by Data<\/div>\n<div style=\"font-size:14px;line-height:1.5;color:#f3f1ff;-webkit-text-fill-color:#f3f1ff;margin-bottom:14px;\">Move from market news to structured research using price action, market context, volume behaviour and multiple research inputs.<\/div>\n<p>      <a href=\"https:\/\/www.wittytrades.com\/Segments.html\" style=\"display:inline-block;background:#f2b84b;color:#1f2740;-webkit-text-fill-color:#1f2740;text-decoration:none;font-weight:900;padding:10px 20px;border-radius:6px;\">View Research Segments<\/a>\n    <\/div>\n<h2>Latest Company Developments<\/h2>\n<div style=\"background:#fbfcfe;border:1px solid #e3e9f0;border-radius:12px;padding:14px;margin:12px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-size:15px;font-weight:800;color:#17324d;margin-bottom:4px;\">US FDA issues EIR with VAI for Goa facility<\/div>\n<div style=\"font-size:12px;color:#708090;margin-bottom:6px;\">23-Sep-2026<\/div>\n<div style=\"line-height:1.55;\">Glenmark Pharmaceuticals announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its manufacturing facility located in Goa. The inspection concluded with a Voluntary Action Indicated (VAI) classification, indicating satisfactory regulatory compliance.<\/div>\n<div style=\"margin-top:8px;font-size:13px;color:#4f5f6e;\"><strong>Why it matters:<\/strong> A VAI classification removes key regulatory overhangs for the Goa plant, securing export visibility and smooth operations for key regulated markets.<\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-size:15px;font-weight:800;color:#17324d;margin-bottom:4px;\">Global respiratory expansion with Ryaltris launch in Brazil<\/div>\n<div style=\"font-size:12px;color:#708090;margin-bottom:6px;\">11-Sep-2026<\/div>\n<div style=\"line-height:1.55;\">The company expanded its international specialty footprint by launching its flagship respiratory product, Ryaltris, in Brazil. This commercial rollout strengthens the company&#x27;s branded respiratory portfolio in key emerging international regions.<\/div>\n<div style=\"margin-top:8px;font-size:13px;color:#4f5f6e;\"><strong>Why it matters:<\/strong> Commercializing high-margin specialty products in large international markets drives revenue diversification and supports medium-term margin expansion.<\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-size:15px;font-weight:800;color:#17324d;margin-bottom:4px;\">Launch of Calcium Gluconate Injection in the USA<\/div>\n<div style=\"font-size:12px;color:#708090;margin-bottom:6px;\">21-Aug-2026<\/div>\n<div style=\"line-height:1.55;\">Glenmark Pharmaceuticals Inc., USA, announced the commercial launch of Calcium Gluconate Injection USP in various dosage formats, including single-dose vials and pharmacy bulk packages. This portfolio addition strengthens the company&#x27;s institutional injectables segment in North America.<\/div>\n<div style=\"margin-top:8px;font-size:13px;color:#4f5f6e;\"><strong>Why it matters:<\/strong> Expands the complex generics portfolio in the highly lucrative US market, supporting steady revenue generation.<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:1fr 1fr;gap:16px;margin:22px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #c8dfd9;border-radius:12px;padding:17px;background:#f0faf7;box-sizing:border-box;min-width:0;\">\n<h2 style=\"margin-top:0;color:#1d6758;\">Relative Performance<\/h2>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>GLENMARK PHARMACEUTICALS<\/th>\n<td>+4.98%<\/td>\n<\/tr>\n<tr>\n<th>Nifty 50<\/th>\n<td>-0.28%<\/td>\n<\/tr>\n<tr>\n<th>Nifty Pharma<\/th>\n<td>+0.64%<\/td>\n<\/tr>\n<tr>\n<th>Vs Nifty 50<\/th>\n<td>+5.26%<\/td>\n<\/tr>\n<tr>\n<th>Vs Sector<\/th>\n<td>+4.34%<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<div style=\"border:1px solid #d4cdeb;border-radius:12px;padding:17px;background:#f7f3ff;box-sizing:border-box;min-width:0;\">\n<h2 style=\"margin-top:0;color:#58448a;\">Technical Context<\/h2>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>Price<\/th>\n<td>\u20b92,441.50<\/td>\n<\/tr>\n<tr>\n<th>Day High \/ Low<\/th>\n<td>\u20b92,441.50 \/ \u20b92,292.10<\/td>\n<\/tr>\n<tr>\n<th>52-Week High<\/th>\n<td>\u20b92,537.60<\/td>\n<\/tr>\n<tr>\n<th>52-Week Low<\/th>\n<td>\u20b91,792.60<\/td>\n<\/tr>\n<tr>\n<th>5-Day Return<\/th>\n<td>-0.81%<\/td>\n<\/tr>\n<tr>\n<th>20-Day Return<\/th>\n<td>-1.17%<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/p><\/div>\n<h2>What Should Traders and Investors Watch Next?<\/h2>\n<ul>\n<li>Sustained delivery volume trends and open interest adjustments in the near term<\/li>\n<li>Execution of newly launched products in the US and Latin American markets<\/li>\n<li>Regulatory updates regarding other manufacturing plants and pending approvals<\/li>\n<li>Price action relative to the 52-week high of \u20b92,537.60<\/li>\n<\/ul>\n<div style=\"background:linear-gradient(120deg,#123c35,#176654 62%,#0d8368);border-radius:12px;padding:23px 28px;margin:28px 0;text-align:center;box-shadow:0 8px 20px rgba(17,80,63,.15);\">\n<div style=\"font-size:19px;font-weight:900;color:#fff;-webkit-text-fill-color:#fff;margin-bottom:8px;\">Get Research-Backed Market Opportunities<\/div>\n<div style=\"font-size:14px;line-height:1.5;color:#effbf6;-webkit-text-fill-color:#effbf6;margin-bottom:14px;\">Explore WittyTrades research segments for trading, swing and investment ideas.<\/div>\n<p>      <a href=\"https:\/\/www.wittytrades.com\/Segments.html\" style=\"display:inline-block;background:#fff;color:#0b6d55;-webkit-text-fill-color:#0b6d55;text-decoration:none;font-weight:900;padding:10px 20px;border-radius:6px;\">Get Research-Backed Recommendations<\/a>\n    <\/div>\n<p style=\"background:#f8fafc;border:1px solid #dce5eb;border-left:4px solid #6b7d90;border-radius:9px;padding:14px 16px;\">\n      <strong>Catalyst note:<\/strong> There is no single same-day trigger announced today, but the sharp rally is backed by heavy volume accumulation and sustained positive operational catalysts.\n    <\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the likely reason for today&#8217;s move?<\/h3>\n<p>Glenmark rallied sharply by nearly 5% accompanied by massive volume expansion (2.5x of 20-day average) and high delivery percentage, outpacing the broader pharmaceutical index. The move appears supported by recent positive regulatory developments like the U.S. FDA clearance for the Goa plant and institutional accumulation.<\/p>\n<h3>Is trading volume elevated?<\/h3>\n<p>Today&#8217;s volume is 1,258,203. The latest 20-day average available is 488,980, equivalent to about 2.57x of the recent average.<\/p>\n<h3>What does the derivatives market show?<\/h3>\n<p>The latest official NSE F&#038;O report is summarised in the Derivative-Market Activity box above.<\/p>\n<h3>Before acting on this stock<\/h3>\n<p>Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the <a href=\"https:\/\/www.wittytrades.com\/Segments.html\"><strong>WittyTrades subscription plans and research segments<\/strong><\/a>.<\/p>\n<div class=\"witty-related\">\n<h2>More Market News from WittyTrades<\/h2>\n<ul style=\"margin:0 0 10px;padding-left:18px;\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-29\/\">Mankind Pharma Share Price Rises Today: Why MANKIND Stock is Moving<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-29\/\">Dr. Reddy&#x27;s Lab Shares Rise: Why DRREDDY Stock is Moving Today<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/apollohosp-share-price-today-2026-09-29\/\">Why Apollo Hospitals Share Price Fell 2.27% Today<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-09-29\/\">Sagility Share Price Falls 2% Today: Key Factors &amp; Analysis<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/policybzr-share-price-today-2026-09-29\/\">Why PB Fintech Share Price Fell Today | Policybazaar Stock News<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/\">View Latest Market News \u2192<\/a><\/p>\n<\/p><\/div>\n<div style=\"background:#f8fafc;border:1px solid #dfe6ed;border-radius:9px;padding:14px 16px;margin:18px 0;\">\n      <strong>Source &amp; methodology:<\/strong><br \/>\n      Market data, exchange filings, company disclosures and reputable business-media reports are collected automatically and summarised for investor context. Material facts are cross-checked where possible; price data may be delayed and a cited development should not be assumed to be the sole cause of a market move unless the evidence supports that conclusion.\n    <\/div>\n<p><strong>Article by:<\/strong> WittyTrades Research Desk<\/p>\n<div class=\"witty-disclaimer\">\n      <strong>Disclaimer:<\/strong><br \/>\n      Investments in securities markets are subject to market risks. Read all related documents carefully before investing.<br \/>\n      Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors.<br \/>\n      This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security.<br \/>\n      Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions.\n    <\/div>\n<p>    <script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"headline\": \"Glenmark Pharma Shares Surge 5%: Why Glenmark Stock is Rising Today\", \"description\": \"Glenmark Pharmaceuticals shares jumped nearly 5% with heavy volume. Check out key catalysts, sector comparison, and stock analysis on WittyTrades.\", \"datePublished\": \"2026-09-29T04:26:14Z\", \"dateModified\": \"2026-09-29T19:13:37.720026+05:30\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"about\": {\"@type\": \"Corporation\", \"name\": \"GLENMARK PHARMACEUTICALS\", \"tickerSymbol\": \"GLENMARK\"}, \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/\"}, \"url\": \"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/\", \"keywords\": [\"why Glenmark share price is rising today\", \"Glenmark Pharma share price news\", \"Glenmark stock surge analysis\", \"Glenmark Pharmaceuticals Nifty Pharma outperformance\", \"Glenmark FDA approval update\"]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals shares jumped nearly 5% with heavy volume. Check out key catalysts, sector comparison, and stock analysis on WittyTrades.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Glenmark Pharma Shares Surge 5%: Why Glenmark Stock is Rising Today","_witty_meta_description":"Glenmark Pharmaceuticals shares jumped nearly 5% with heavy volume. Check out key catalysts, sector comparison, and stock analysis on WittyTrades.","_witty_primary_phrase":"why Glenmark share price is rising today","_witty_reason_label":"Strong volume-backed buying and sector outperformance","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[],"class_list":["post-610","post","type-post","status-publish","format-standard","hentry","category-market-movers","category-stocks-in-news"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=610"}],"version-history":[{"count":2,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/610\/revisions"}],"predecessor-version":[{"id":723,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/610\/revisions\/723"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}